SCHEMBL22097151

SCHEMBL22097151

c1ccc(-c2nc(-c3ccc4c(c3)c3ccccc3c3c4ccc4c5cc6c7ccccc7c7ccccc7c6cc5n(-c5ccccc5)c43)nc3ccc4ccccc4c23)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
MAPT P10636 4/20 0.32
ALDH1A1 P00352 3/20 0.32
KDM4E B2RXH2 3/20 0.32
HPGD P15428 2/20 0.32
LMNA P02545 3/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
RECQL P46063 1/20 0.32
HTT P42858 2/20 0.32
NPY1R P25929 1/20 0.32
NPY2R P49146 1/20 0.32
WHR1 P49842 1/20 0.32
POLB P06746 1/20 0.30
HSP90AA1 P07900 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22097035 0.93 PTGES (0.36) PTGESMEN1KMT2AATMMAPT
SCHEMBL22096960 0.93 ATM (0.36) PTGESMEN1KMT2AATMMAPT
SCHEMBL22096947 0.90 PTGES (0.38) PTGESMEN1KMT2AATMMAPT
SCHEMBL22097139 0.85 CYP1A1 (0.33) MEN1KMT2AATMWHR1
SCHEMBL22097037 0.83 PTGES (0.36) PTGESMEN1KMT2AATMMAPT
SCHEMBL22097156 0.81 MEN1 (0.45) MEN1KMT2AATMMAPTALDH1A1
SCHEMBL22097024 0.80 ATM (0.34) MEN1KMT2AATMKDM4EWHR1
SCHEMBL17828978 0.80 PTGES (0.40) PTGESMEN1KMT2AATMMAPT
SCHEMBL22097008 0.80 MEN1 (0.48) MEN1KMT2AATMMAPTALDH1A1
SCHEMBL22097166 0.80 MEN1 (0.50) MEN1KMT2AATMMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11236075-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-02-01 US disclosed
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11236075-B2 Organic compound and organic electroluminescence device using the same ICMT, OR10J3, PIEZO1 PTGES 2246/4885MEN1 1207/4885KMT2A 2500/4885
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME ICMT, OR10J3, PIEZO1 PTGES 2246/4885MEN1 1207/4885KMT2A 2500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.